[{"uuid": "fd9aeefb-4bf6-3a63-b200-79db8b556928", "title": "Insider Stock Buying Of Candel Therapeutics Delivers Return On US$3.00m Investment", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/insider-stock-buying-candel-therapeutics-122117356.html", "providerPublishTime": 1737202877, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eZ0FiSKCVDYnTK6X1bRieQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL"]}, {"uuid": "e93c2c9f-d520-381a-8d4f-9e4f45ce5fc5", "title": "Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/candel-therapeutics-provides-corporate-highlights-130000779.html", "providerPublishTime": 1736773200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OVaui3MA0nAIzdRidF5_Jg--~B/aD0xNTE4O3c9MzMyNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 3325, "height": 1518, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pra.bB_MHESdR2XjuTwDtw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL"]}, {"uuid": "45fef0b5-4d44-3861-87ff-5c1af620cee2", "title": "After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win", "publisher": "Pharma Voice", "link": "https://finance.yahoo.com/m/45fef0b5-4d44-3861-87ff-5c1af620cee2/after-layoffs%2C-a-viral.html", "providerPublishTime": 1736405084, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JDXLduIcc_MHKs4Cv2pGYg--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a", "width": 1280, "height": 720, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cuvbLlOlbSceNbN3YhwgRg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL"]}, {"uuid": "c5248cf3-f2c8-3cb0-b7f6-29bc8d7f6cd5", "title": "CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/cadl-stock-soars-phase-iii-153100669.html", "providerPublishTime": 1734017460, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sb.6qRd7FfGt7.wCjWz2vw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/y6B.X5ymHvNNdOly.Nnp7w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL", "PFE", "CELG-RT"]}, {"uuid": "499dbdc3-c0d6-37d1-b688-e6ac899d7850", "title": "Candel Therapeutics Closes Securities Offering to Raise $92 Million", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/candel-therapeutics-closes-securities-offering-225510529.html", "providerPublishTime": 1734389710, "type": "STORY", "relatedTickers": ["CADL"]}, {"uuid": "f1048fa3-2ef2-3f90-af5f-d40e5438b075", "title": "Candel Therapeutics Prices $80 Million Public Offering", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/candel-therapeutics-prices-80-million-091238576.html", "providerPublishTime": 1734081158, "type": "STORY", "relatedTickers": ["CADL"]}, {"uuid": "b64c6f97-9f28-355b-a226-17dc62941964", "title": "Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/candel-therapeutics-announces-closing-public-210100866.html", "providerPublishTime": 1734382860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OVaui3MA0nAIzdRidF5_Jg--~B/aD0xNTE4O3c9MzMyNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 3325, "height": 1518, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pra.bB_MHESdR2XjuTwDtw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL"]}, {"uuid": "c9edc6ff-bc49-3388-bfd2-70a9979a1be7", "title": "Top Premarket Gainers", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-premarket-gainers-124051661.html", "providerPublishTime": 1733920851, "type": "STORY", "relatedTickers": ["CADL", "RZLVW"]}, {"uuid": "5e23ece9-5cb1-350f-bcb1-7b8c6ca459cb", "title": "Candel Therapeutics Says Prostate Cancer Drug Trial Meets Primary Endpoint; Shares Jump", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/candel-therapeutics-says-prostate-cancer-124822955.html", "providerPublishTime": 1733921302, "type": "STORY", "relatedTickers": ["CADL"]}, {"uuid": "3d1d490c-7197-3ba2-8f81-db76ab685814", "title": "Candel Therapeutics Announces Pricing of Public Offering", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/candel-therapeutics-announces-pricing-public-040000271.html", "providerPublishTime": 1734062400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OVaui3MA0nAIzdRidF5_Jg--~B/aD0xNTE4O3c9MzMyNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 3325, "height": 1518, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pra.bB_MHESdR2XjuTwDtw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL"]}, {"uuid": "8bcd398a-192d-3e58-a1d4-76099b6b2537", "title": "Candel Therapeutics Announces $80 Million Proposed Public Offering", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/candel-therapeutics-announces-80-million-215100990.html", "providerPublishTime": 1734040260, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OVaui3MA0nAIzdRidF5_Jg--~B/aD0xNTE4O3c9MzMyNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 3325, "height": 1518, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pra.bB_MHESdR2XjuTwDtw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0967bb083514f87a91b7c0ba0cacf3b2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL"]}, {"uuid": "260fe785-1a23-3eac-9d65-a199cbc35d7b", "title": "Candel Therapeutics Stock Surges Over 100% - Here's Why", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/candel-therapeutics-stock-surges-over-141944723.html", "providerPublishTime": 1733926784, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nDjxpCLgOwkmuNsyCdOK1g--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/a19e371962c82e7dfb3607b879d698c0", "width": 983, "height": 553, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/61YiS7svlCFFAsl_EWiPcw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/a19e371962c82e7dfb3607b879d698c0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CADL"]}]